Article
Ion channel blockers and glioblastoma risk and outcome: a nested case-control and retrospective cohort studies.
Pharmacoepidemiology and drug safety - 1 Oct 2016
Boursi Ben, Han Harry J, Haynes Kevin, Mamtani Ronac, Yang Yu-Xiao
Abstract excerpt
PURPOSE: Mutations in ion channels are common among patients with glioblastoma multiforme (GBM) and promote cell migration and invasion. We sought to evaluate the association between the use of specific ion channel blockers such as digoxin, amiodarone, diltiazem and verapamil and GBM risk and survival. METHODS: We conducted a nested case-control study in a large primary care database from the UK. Cases were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
